Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes

PURPOSE: To assess clinical antimicrobial efficacy results obtained with besifloxacin ophthalmic suspension, 0.6%, administered three times a day (TID) for 5 days, integrated across three clinical trials of bacterial conjunctivitis and to investigate any microbiological eradication failures. METHODS...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Morris, Timothy W, Gearinger, Lynne S, Usner, Dale W, Paterno, Michael R, DeCory, Heleen H, Comstock, Timothy L, Haas, Wolfgang
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2011
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3198409/
https://ncbi.nlm.nih.gov/pubmed/22034555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S23518
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars